Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAD
3476
DELISTED
Rite Aid Corporation
RAD
| $5.65M | ﹤0.01% |
838,166
+571,611
| +214% | +$3.78M |
|
3477
Sixth Street Specialty
TSLX
$1.78B
| $5.64M | ﹤0.01% |
305,131
+149,389
| +96% | +$3.16M |
|
|
FTCH
3478
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $5.64M | ﹤0.01% |
788,200
+190,300
| +32% | +$1.95M |
|
3479
Takeda Pharmaceutical
TAK
$56.3B
| $5.64M | ﹤0.01% |
401,766
+58,083
| +17% | +$829K |
|
3480
iShares MSCI China ETF
MCHI
$6.16B
| $5.63M | ﹤0.01% |
+100,794
| New | +$5.17M |
|
3481
Bolt Biotherapeutics
BOLT
$6.44M
| $5.62M | ﹤0.01% |
137,766
+158
| +0.1% | +$6.13K |
|
3482
CALL
Aramark
ARMK
$16.4B
| $5.62M | ﹤0.01% |
254,009
-13,989
| -5% | -$346K |
|
3483
CALL
Coty
COTY
$2.51B
| $5.6M | ﹤0.01% |
699,500
-355,900
| -34% | -$2.67M |
|
|
DVAX
3484
DELISTED
Dynavax Technologies
DVAX
| $5.6M | ﹤0.01% |
444,924
+72,589
| +19% | +$771K |
|
|
SWN
3485
CALL
DELISTED
Southwestern Energy Company
SWN
| $5.6M | ﹤0.01% |
896,300
+191,800
| +27% | +$1.48M |
|
3486
United States Natural Gas Fund
UNG
$487M
| $5.6M | ﹤0.01% |
+73,637
| New | +$7.59M |
|
|
NKLA
3487
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $5.6M | ﹤0.01% |
39,187
+12,970
| +49% | +$2.65M |
|
|
MON
3488
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
| $5.6M | ﹤0.01% |
569,784
-499,001
| -47% | -$4.9M |
|
|
ATAQ
3489
DELISTED
Altimar Acquisition Corp III
ATAQ
| $5.59M | ﹤0.01% |
570,238
-24,518
| -4% | -$240K |
|
3490
Annexon
ANNX
$1B
| $5.59M | ﹤0.01% |
1,483,663
-257,307
| -15% | -$786K |
|
3491
Avantis Core Fixed Income ETF
AVIG
$1.96B
| $5.59M | ﹤0.01% |
130,466
+107,465
| +467% | +$4.67M |
|
|
TWOU
3492
PUT
DELISTED
2U Inc
TWOU
| $5.59M | ﹤0.01% |
17,803
-2,954
| -14% | -$912K |
|
3493
CALL
Vanguard Total World Stock ETF
VT
$81.8B
| $5.59M | ﹤0.01% |
65,500
-47,900
| -42% | -$4.43M |
|
|
ITCI
3494
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.59M | ﹤0.01% |
97,900
+16,100
| +20% | +$913K |
|
|
SWI
3495
DELISTED
SolarWinds Corporation Common Stock
SWI
| $5.59M | ﹤0.01% |
544,932
+41,344
| +8% | +$490K |
|
3496
PUT
Lumentum
LITE
$82.1B
| $5.58M | ﹤0.01% |
70,300
-700
| -1% | -$59.8K |
|
3497
CALL
Deutsche Bank
DB
$72.5B
| $5.58M | ﹤0.01% |
638,500
-95,300
| -13% | -$1.02M |
|
3498
PUT
Lemonade
LMND
$4.07B
| $5.58M | ﹤0.01% |
305,600
-213,500
| -41% | -$4.5M |
|
3499
Cathay General Bancorp
CATY
$4.33B
| $5.58M | ﹤0.01% |
142,505
+114,292
| +405% | +$4.66M |
|
|
SGI
3500
CALL
Somnigroup International
SGI
$13.9B
| $5.58M | ﹤0.01% |
261,000
+158,500
| +155% | +$4.08M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.